This year, about 40 original medicines expired in patent
Including ‘Viread,’ 40 original medicines owned by multinational pharmaceutical companies with more than KRW 100 billion annual sales will be expired in patent this year.
According to the pharmaceutical industry, starting with the AstraZeneca’s asthma treatment ‘Symbicort Turbuhaler,’ patents of...
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.